Is HFNC noninferior to NIV for Acute Respiratory Failure?

January 24, 2025 00:31:44
Is HFNC noninferior to NIV for Acute Respiratory Failure?
Critical Care Perspectives in Emergency Medicine
Is HFNC noninferior to NIV for Acute Respiratory Failure?

Jan 24 2025 | 00:31:44

/

Show Notes

Both NIV and HFNC are used to treat patients with acute respiratory failure.  Current guidelines recommend NIV for acute respiratory failure caused by COPD and acute cardiogenic pulmonary edema.  However, NIV may be hard for some patients to tolerate. When compared to low-flow oxygen therapy, HFNC has been shown to improve oxygenation, improve alveolar recruitment, and enhance clearance of secretions. HFNC may be easier to use and tolerate than NIV, but there remains uncertainty regarding the effectiveness of HFNC compared to NIV for acute hypoxemic respiratory failure. In this podcast, we discuss the RENOVATE trial that sought to compare HFNC with NIV on rates of intubation in patients with acute respiratory failure.

Other Episodes

Episode 0

September 16, 2021 00:29:18
Episode Cover

The TOMAHAWK Study

The COACT trial demonstrated no improvement in 90-day mortality for post-arrest patients without evidence of an ST-segment elevation MI who were randomized to immediate...

Listen

Episode

January 27, 2017 00:24:56
Episode Cover

The Complicated Alcohol Withdrawal Patient

Bryan Hayes is back!  In this podcast, we discuss pitfalls in the use of benzodiazpines along with current evidence on adjunctive treatments including propofol,...

Listen

Episode 0

May 26, 2020 00:27:09
Episode Cover

HFNC in COVID-19 Patients - Helpful or Harmful?

As we gain more experience managing critically ill patients with COVID-19 infection there has been a shift away from immediate intubation and towards more...

Listen